|
ZNF708 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.262000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.022200E-01 |
| Normal-vs-Stage2 |
2.038400E-01 |
| Normal-vs-Stage3 |
5.415400E-01 |
| Normal-vs-Stage4 |
3.627600E-01 |
| Stage1-vs-Stage2 |
4.806600E-01 |
| Stage1-vs-Stage3 |
4.591700E-02 |
| Stage1-vs-Stage4 |
3.113800E-02 |
| Stage2-vs-Stage3 |
1.097570E-01 |
| Stage2-vs-Stage4 |
7.865900E-02 |
| Stage3-vs-Stage4 |
7.273400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.525400E-01 |
| Normal-vs-AfricanAmerican |
9.456400E-01 |
| Normal-vs-Asian |
8.588400E-02 |
| Caucasian-vs-AfricanAmerican |
6.370000E-01 |
| Caucasian-vs-Asian |
2.681800E-01 |
| AfricanAmerican-vs-Asian |
1.664440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.099000E-01 |
| Normal-vs-Female |
8.448200E-02 |
| Male-vs-Female |
2.648400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.757400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.263440E-01 |
| Normal-vs-Age(61-80Yrs) |
8.499200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.870420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.444400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.365000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.888560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.272000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.984300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.764600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.404200E-03 |
| Normal-vs-Grade 2 |
4.973600E-02 |
| Normal-vs-Grade 3 |
4.683400E-01 |
| Normal-vs-Grade 4 |
1.733790E-01 |
| Grade 1-vs-Grade 2 |
2.783000E-01 |
| Grade 1-vs-Grade 3 |
4.616500E-03 |
| Grade 1-vs-Grade 4 |
7.657400E-03 |
| Grade 2-vs-Grade 3 |
1.482030E-03 |
| Grade 2-vs-Grade 4 |
4.876300E-03 |
| Grade 3-vs-Grade 4 |
3.691800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.567700E-02 |
| Normal-vs-ccB subtype |
9.641600E-01 |
| ccA subtype-vs-ccB subtype |
1.574350E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.930600E-01 |
| Normal-vs-N1 |
2.367600E-01 |
| N0-vs-N1 |
2.070000E-01 |
|
|
